108
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Kell Expression on Myeloid Progenitor Cells

, &
Pages 479-485 | Published online: 01 Jul 2009

  • Cosombs, R.R.A., Mourant, A.E. and Race, R.R. (1946) "In vivo isosensitisation of red cells in babies wit haemolytic disease", Lancet i, 264-266.
  • Daniels, G.L., Austee, D.J. Cartron, J-P., et al., (1995) "Blood group terminology 1995. From the ISBT working party on terminology for red cell surface antigens", Vox Sang. 69, 265-279.
  • Daniels, G.L., Anstee, D.J., Cartron, J-P., et al., (1999) "Terminology for red cell surface antigens", Vox Sang. 77, 52-57.
  • Lee, S. (1997) "Molecular basis of Kell blood group phenotypes", Vox Sang. 73, 1-11.
  • Petty, A.C., Daniels, G.L. and Tippett, P. (1994) "Application of the MAIEA assay to the Kell blood group system", Vox Sang. 66(3), 216-224.
  • Jongerius, J.M., Daniels, G.L., Overbeeke, M.A., Petty, A.C., Reid, M., Oyen, R., Rijksen, H. and van Leeuwen, H.H. (1996) "A new low-incidence antigen in the Kell blood group system: VLAN (KEL25)", Vox Sang. 71(1), 43-47.
  • Lee, S., Russo, D.C., Reiner, A.P., Lee, J.H., Sy, M.Y., Telen, M.J., Judd, W.J., Simon, F., Rodrigues, M.J., Chabert, T., Poole, J., Jovanovic-Srzentic, S., Levene, C., Yahalom, V. and Redman, C.M. (2001) "Molecular defects underlying the Kell null phenotype", J. Biol. Chem. 24, 234-238.
  • Yu, L.C., Twu, Y.C., Chang, C.Y. and Lin, M. (2001) "Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens", J. Biol. Chem. 276(13), 10247-10252.
  • Reid, M.E. and Lomas-Francis, C. (1997) The Blood Group Antigen Facts Book (Academic Press, New York).
  • Russo, D., Redman, C. and Lee, S. (1998) "Association of XK and Kell blood group proteins", J. Biol. Chem. 273, 13950-13957.
  • Curbonnet, F., Hattab, C., Collec, E., Le Van Kim, C., Catron, J.P. and Bertrand, O. (1997) "Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides", Br. J. Haematol. 96, 857-863.
  • Russo, D.C.W., Lee, S., Reid, M. and Redman, C.M. (1994) "Topology of Kell blood group protein and the expression of multiple antigens by transfected cells", Blood 84, 3518-3523.
  • Lee, S., Zambas, E.D., Marsh, W.L. and Redman, C.M. (1993) "The human Kell group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells", Blood 81, 2804-2809.
  • Daniels, G.L., Hadley, A.C. and Green, C.A. (1999) "Fetal anaemia due to anti-K may result from immune destruction of early erythroid progenitors", Transfers. Med. 9(1), 16.
  • Vaughan, J.I., Warwick, R., Letsky, E., Nicolini, U., Rodeck, C.H. and Fisk, N.M. (1994) "Erythropoietic suppression in fetal anemia because of Kell alloimmunization", Am. J. Obstet. Gynecol. 171, 247-252.
  • Weiner, C.P. and Widness, J.A. (1996) "Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia", Am. J. Obstet. Gynecol. 174, 547-551.
  • Southcott, M.J.G., Tanner, M.J.A. and Anstee, D.J. (1999) "The expression of human blood group antigens during erythropoiesis in a cell culture system", Blood 93, 4425-4435.
  • Russo, D., Wu, X., Redman, C.M. and Lee, S. (2000) "Expression of Kell blood group protein in nonerythroid tissues", Blood 96, 340-346.
  • Camara-Clayette, V., Rahuel, C., Lopez, C., Hattab, C., Verkarre, V., Bertrand, O. and Cartron, J.P. (2001) "Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells", Biochem. J. 356, 171-180.
  • Lee, S., Zambas, E.D. Marsh, W.I., and Redmann, C.M. (1991) "Molecular cloning and primary structure of Kell blood group protein", Proc. Natl Acad. Sci USA 88, 6353-6357.
  • Lee, S., Lin, M.H., Farmar, J.G., Cao, Y. and Redman, C.M. (1998) "Kell blood group protein proteolytically cleaves vasoactive peptides", Blood 92, 4a.
  • Lee, S., Russo, D. and Redman, C. (2000) "Functional and structural aspects of the Kell blood group system", Transfus. Med. Rev. 14(2), 93-103.
  • Lee, S., Russo, D. and Redman, C. (2000) "The Kell blood group system: Kell and XK membrane proteins", Semin. Hemtol. 37(2), 113-121.
  • De Jonge, N., Martens, J.E., Milani, A.L., Krijnen, J.L.M., van Krimpen, C. and Ponjee, G.A.E. (1996) "Haemolytic disease of the newborn due to anti-K antibodies", E. J. Obstet. Gynecol. 67, 69-72.
  • Bowman, J.M., Harman, F.A. and Manning, C.R. (1989) "Erythroblastosis fetalis produced by anti-k", Vox Sang. 56, 187-189.
  • Duguid, J.K.M. and Bromilow, I.M. (1990) "Haemolytic disease of the newborn due to anti-k", Vox Sang. 58, 69.
  • Sakuma, K., Suzuki, H., Ohto, H., Tsuneyama, H. and Uchikawa, M. (1994) "First case of hemolytic disease of the newborn due to anti-Ula antibodies", Vox Sang. 66, 293-294.
  • Gordon, M.C, Kennedy, M.S., O'Shaughnessy, R.W. and Waheed, A. (1995) "Severe hemolytic disease of the newborn due to anti-Js(b)", Vox Sang. 69, 140-141.
  • Bowman, J.M., Pollock, J.M., Manning, F.A., Hannan, C.R. and Menticoglou, S. (1992) "Maternal Kell blood group alloimmunization", Obstet. Gynecol. 79, 239-244.
  • Bakos, O., Ewald, U. and Lindgren, P.G. (1998) "Fetal cardiocentesis in care of severe Kell immunisation", Fetal Diagn. Ther. 13(6), 372-374.
  • Grant, S.R., Kilby, M.D., Meer, L., Weaver, J.B., Cabra, G.S. and Whittle, M.J. (2000) "The outcome of pregnancy in Kell alloimmunisation", BJOG 107(4), 481-485.
  • Issitt, P.D. and Anstee, D.J. (1998) Applied Blood Group Serology, (Durham, NC). Montgomery Scientific Publications, Durham, NC.
  • Mayne, K.M., Bowell, P.J. and Pratt, G.A. (1990) "The significance of anti-Kell sensitization in pregnancy", Clin. Lab. Haematol. 12, 379-385.
  • McKenna, D.S., Nagaraja, H.N. and O'Shaughnessy, R. (1999) "Management of pregnancies complicated by anti-Kell isoimmunization", Obstet. Gynecol. 93, 667-673.
  • Gorlin, J.B. and Kelly, L. (1994) "Alloimmunisation via previous transfusion places female Kpb-negative recipients at risk of having children with clinically significant hemolytic disease of the newborn", Vox Sang. 66, 46-48.
  • Mollison, P.L., Engelfriet, C.P. and Contreras, M. (1997) Blood Transfusion in Clinical Medicine, 10th ed. (Blackwell, Oxford), pp. 390-424.
  • Ahaded, A., Brossard, Y., Debbia, M. and Lambin, P. (2000) "Quanitative determination of anti-K (KEL 1) IgG and IgG subclasses in serum of severely alloimmunized pregnant women by ELISA", Transfusion 40(10), 1239-1245.
  • Van Dijk, B.A., Dooren, M.C. and Overbeeke, M.A. (1995) "Red cell antibodies in pregnancy: there is no critical titre", Transfus. Med. 5, 199-202.
  • Hadley, A.G. (1995) "In vitro assay to predict the severity of hemolytic disease of the newborn", Transfus. Med. Rev. 9, 302-313.
  • Dhodapkar, K.M. and Blei, F. (2001) "Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin", J. Pediatr. Hematol. Oncol. 23, 69-70.
  • Seyfried, H., Gorska, B., Maj, S., Sylwestrowicz, T., Giles, C.M. and Goldsmith, K.L.B. (1972) "Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia", Vox Sang. 23, 528-536.
  • Oyen, R., Halverson, G.R. and Reid, M.E. (1997) "Review: conditions causing weak expression of Kell system antigens", Immunohemaotology 3, 75-79.
  • Marsh, W.L., Oyen, R., Alicea, E., Linter, M. and Hortoti, S. (1979) "Autoimmune hemolytic anemia and the Kell blood groups", Am. J. Hematol. 7, 155-162.
  • Beck, M.L., Marsh, W.L., Pierce, S.R., DiNapoli, J., Oyen, R. and Nichols, M.E. (1979) "Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: a second example", Transfusion 19, 197-202.
  • Williamson, L.M., Poole, J. and Redman, C (1994) "Transient loss ot proteins carrying Kell and Lutheran red cell antigens during constructive relapse of autoimmune thrombocytopenia", Br. J. Haematol. 87, 805-812.
  • Manny, N., Levene, C., Sela, R., Johnson, C.L., Mueller, K.A. and Marsh, W.U (1983) "Autoimmunity and the Kell blood groups: auto-anti-Kpb in a Kp(a+b - ) patient", Vax Sang. 45, 252-256.
  • Messner, H.A. and Jamal, N. (1993) "Cell culture assessment of hemmopoietic progenitors in boue marrow transplantation", J. Hematother. 2, 19-25.
  • Rowley, S.D., Sharkis, S.J., Hattenburg, C. and Sensenbrenner, L.L. (1987) "Culture from human bone marrow of blast progenitor cells with an extensive proliferate capacity", Blood 68, 804-808.
  • Messner, H.A., Jamai, N. and Izaguirre, C. (1982) "The growth of large megakaryocyte colonies from human bone marrow", J. Cell Physiol. Suppl. 1, 45-51.
  • Kauser, A.A. and Messner, H.A. (1979) "Identification of megakaryocytes. macrophages, and eosinophils in colonies of human bone marrow containing neutrophil granulocytes and erythroblasts", Blood 53, 1023-1027.
  • Turner, A.J. and Murphy, L.J. (1996) "Molecular pharmacology of endothelin converting enzymes", Biochem. Pharmacol. 51, 91.
  • Turner, A.J. and Tanzawa, K. (1997) "Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX", FASEB J. 11, 355.
  • Belhagene, N., Maulon, L., Guerin, S., Ricci, J.E., Mari, B., Colin, Y., Cartron, J.P. and Auberger, P (1998) "Differential expression of the Kell blood group and CD10 antigens: two related membrane melallopeptidases during differentiation of K562 cells by phorbol ester and hemin", FASEB J. 12, 531-539.
  • Lee, S., Lin, M., Mele, A., Cao, Y., Farmar, J., Russo, D. and Redman, C. (1999) "Proteolytic processing of big endothelin-3 by the Kell blood group protein", Blood 94, 1440-1450.
  • Vaughan, J.I., Manning, M., Warwick, R.M., Letsky, E.A., Murray, N.A. and Roberts, I.A.G. (1998) "Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia", N. Engl. J. Med. 338, 798-803.
  • Wagner, T., Bernaschek, G. and Geissler, K. (2000) "Kell related antibodies inhibit megakaryopoiesis", N. Engl. J. Med. 343(1), 72.
  • Geissler, K., Valent, P., Mayer, P., Liehl, E., Hinterberger, W., Lechner, K. and Bettelheim, P. (1990) "Recombinant human interIeukin-3 expands the pool of circulating hcmatopoietic progenitor cells in primales-synergism with recombinant human granulocyte/macrophage colony-stimulating factor", Blood 75, 2305-2313.
  • Wagner, T., Berer, A., Lanzer, G. and Geissler, K. (2000) "Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cell", Br. J. Haematol. 110, 409-411.
  • Dwyer, J.M. (1992) "Manipulating the immune system with immunoglobulin", N. Engl. J. Med. 326, 107-116.
  • Ho, M., Chelly, J., Carter, N., Danek, A., Crocker, B. and Monaco, A.P. (1994) "Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein", Cell 77(6), 869-880.
  • Shimada, K., Takahashi, M., Tumer, A.J. and Tanzawa, K. (1996) "Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11", Biochem. J. 315, 863-867.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.